Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion description "[In contrast, downregulation of clusterin by 2'-O-(2-methoxy)ethyl (2'MOE)-modified antisense oligonucleotides (AS-ODN) directed against clusterin mRNA significantly reduced drug-resistance, i.e., decreased survival of melanoma cells in the presence of cytotoxic drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion evidence source_evidence_curated NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion SIO_000772 15955107 NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion wasDerivedFrom ctd_human-20130708 NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_assertion wasGeneratedBy ECO_0000218 NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP12063.RAE0AVL5nG0eirTSRSEso_hR7mVss3YiOZn8JedyZeMnI130_provenance.